370 days ago • Posted by Djellza Kolloni

Chemical M&A valuations have skyrocketed

The desire to focus on high-margin, specialty sectors like the manufacturing of chemicals to increase immunity in Covid-19 vaccines has fueled the quick pace of carve-outs and buyouts. According to Young & Partners, cheap financing has helped M&A rebound, with $25.1 billion in deals in the chemicals sector in the first quarter compared to $41.3 billion for the entire year 2020. Source: Financial Times